CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer.
Xie C, Jiang XH, Zhang JT, Sun TT, Dong JD, Sanders AJ, Diao RY, Wang Y, Fok KL, Tsang LL, Yu MK, Zhang XH, Chung YW, Ye L, Zhao MY, Guo JH, Xiao ZJ, Lan HY, Ng CF, Lau KM, Cai ZM, Jiang WG, Chan HC.
Xie C, et al. Among authors: ng cf.
Oncogene. 2013 May 2;32(18):2282-91, 2291.e1-7. doi: 10.1038/onc.2012.251. Epub 2012 Jul 16.
Oncogene. 2013.
PMID: 22797075